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ABSTRACT BODY: 
Objectives: Ovarian cancer is a silent killer, metastasising throughout the abdomen before causing symptoms. So far,
research concerning the immune system in ovarian cancer has focussed on the intratumoral immune changes. The
peripheral immune landscape in ovarian cancer remains largely undiscovered.
Methods: In 39 patients with invasive ovarian cancer, blood was taken at diagnosis. Simultaneously, a tumor biopsy
from the primary tumor and/or metastasis was prelevated in 31 of them. Activated CD8+ T cells (CD8+CD69+) were
measured in blood, CD8+ TIL (tumor infiltrating lymphocytes) were stained in tumor tissue.
Results: A high amount of CD8+ TIL (above lowest tertile) resulted in an increased progression free (PFS) and overall
survival (OS). In contrast, an increase in CD8+CD69+ T cells in blood resulted in a decrease of PFS and OS. The
curve matching blood and tumor tissue samples demonstrated an inverse correlation between the presence of CD8 T
cells in blood versus tumor.
Conclusions: This study demonstrates for the first time a relationship between locally and systemically measured
tumor immunity. This opens new perspectives to use immune cells as a liquid biopsy in the diagnosis of ovarian
cancer.
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